Abatacept (CTLA4-Ig) ( DrugBank: Abatacept )

1 disease

ID	Disease name (Link within this page)	Number of trials
44	Wegener granulomatosis	4

44. Wegener granulomatosis

Clinical trials : 92 / Drugs : 106 - (DrugBank : 27) / Drug target genes : 22 - Drug target pathways : 78

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2013-005535-24-GB (EUCTR)	07/06/2016	03/12/2015	Abatacept (CTLA4-Ig)for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis (We ...	Abatacept (CTLA4-Ig)for the treatment of relapsing, non-severe, granulomatosis with polyangiitis (We ...	Granulomatosis with polyangiitis (GPA; Wegener's granulomatosis) MedDRA version: 19.0;Level: LLT;Cla ...	Trade Name: Orencia Product Name: Abatacept INN or Proposed INN: Abatacept	Univeristy of South Florida	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 3	United States;France;Mexico;Canada;Spain;Ireland;Australia;Germany;Switzerland;Italy;United Kingdom; ...
2	EUCTR2013-005535-24-IE (EUCTR)	04/05/2016	11/02/2016	Abatacept (CTLA4-Ig)for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Abatacept (CTLA4-Ig)for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Relapsing, Non Severe, Granulomatosis with Polyangiitis (Wegener’s) MedDRA version: 20.0;Level: LLT; ...	Trade Name: Orencia Product Name: Abatacept (CTLA4-Ig) INN or Proposed INN: ABATACEPT	University of South Florida	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	66	Phase 3	United States;Spain;Ireland;Italy;Switzerland;United Kingdom;France;Mexico;Canada;Belgium;Australia; ...
3	NCT02108860 (ClinicalTrials.gov)	April 2015	27/3/2014	Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)	Abatacept (CTLA4-Ig)for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (We ...	Granulomatosis With Polyangiitis (Wegener's);Granulomatosis With Polyangiitis;Wegener's Granulomatos ...	Drug: Abatacept;Drug: placebo	University of South Florida	The Cleveland Clinic;Bristol-Myers Squibb;University of Pennsylvania;National Institutes of Health ( ...	Recruiting	15 Years	N/A	All	66	Phase 3	United States;Canada;Germany;Ireland;United Kingdom
4	EUCTR2013-005535-24-DE (EUCTR)		18/08/2017	Abatacept (CTLA4-Ig)for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Abatacept (CTLA4-Ig)for the Treatment of Relapsing, Non Severe, Granulomatosis with Polyangiitis (We ...	Relapsing, Non Severe, Granulomatosis with Polyangiitis (Wegener’s) MedDRA version: 20.0;Level: LLT; ...	Trade Name: Orencia Product Name: Abatacept (CTLA4-Ig)	University of South Florida	NULL	NA			Female: yes Male: yes	150	Phase 3	United States;Spain;Ireland;Switzerland;United Kingdom;Italy;France;Mexico;Canada;Belgium;Australia; ...

First Previous1Next Last